ALLMedicine™ Hydrocephalus Center
Research & Reviews 3,934 results
https://doi.org/10.1016/j.semperi.2022.151598
Seminars in Perinatology; Vinukonda G, La Gamma EF
May 20th, 2022 - In this report, we summarize evidence on mechanisms of injury after intraventricular hemorrhage resulting in post-hemorrhagic white matter injury and hydrocephalus and correlate that with the possibility of cellular therapy. We describe how two st...
https://doi.org/10.1007/s00432-022-04053-7 10.1093/neuonc/noy186 10.1097/01.RLI.0000067488.57101.bd 10.1093/neuonc/now183 10.1016/S1470-2045(17)30689-7 10.1212/WNL.0b013e3181dc1a69 10.3390/cancers13040732 10.1007/s11060-010-0524-y 10.1016/j.lungcan.2011.11.012 10.1016/S1474-4422(06)70443-4 10.1053/ctrv.1999.0119 10.3233/CBM-190187 10.1093/nar/gkw227 10.1093/neuonc/noab101 10.1097/WCO.0000000000000393 10.1093/neuonc/noz024 10.1007/s12282-020-01058-3 10.1111/1759-7714.13123 10.1016/j.ajhg.2017.01.004 10.1093/annonc/mdy009 10.1016/j.ctrv.2015.12.004 10.1093/bioinformatics/btu549 10.3390/cancers13122888 10.1016/s0065-2423(06)42001-1 10.1093/annonc/mdy544 10.3390/cells8101195 10.1371/journal.pcbi.1004873 10.1016/j.jns.2020.116706 10.1007/s11060-017-2691-6 10.3233/CBM-130338 10.1016/j.cca.2017.04.023 10.1001/jamanetworkopen.2021.20040 10.1155/2017/2467870 10.1016/j.jtho.2019.01.007 10.1136/jclinpath-2018-205414
Journal of Cancer Research and Clinical Oncology; Wang Y, Luo N et. al.
May 19th, 2022 - Leptomeningeal metastases (LMs) are highly invasive which leads to poor prognosis, but the accurate diagnosis of LM is challenging. It is necessary to investigate more advanced diagnostic methods to realize precision medicine. The main purpose of ...
https://doi.org/10.1080/02688697.2022.2074373
British Journal of Neurosurgery; Hasanain AA, Soliman MAR et. al.
May 18th, 2022 - Congenital hydrocephalus affects approximately one in 1000 newborn children and is fatal in approximately 50% of untreated cases. The currently known management protocols usually necessitate multiple interventions and long-term use of healthcare r...
https://doi.org/10.1007/s10278-022-00654-3 10.1371/journal.pone.0204926 10.1148/radiol.2017161216 10.1002/mds.28087 10.1016/j.neuroimage.2005.02.018 10.1109/42.906424 10.1016/j.media.2016.10.004 10.1016/j.neuroimage.2018.11.042 10.1159/000186501 10.1212/WNL.0000000000000342 10.1088/1741-2560/10/6/066004 10.1148/radiol.10100252 10.2307/1932409 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I 10.11613/BM.2012.031 10.1007/s00701-020-04447-x
Journal of Digital Imaging; Huang Y, Moreno R et. al.
May 18th, 2022 - In large clinical centers a small subset of patients present with hydrocephalus that requires surgical treatment. We aimed to develop a screening tool to detect such cases from the head MRI with performance comparable to neuroradiologists. We leve...
https://doi.org/10.3233/NRE-220010
NeuroRehabilitation Umemori T, Higuchi T et. al.
May 17th, 2022 - The clinical spectrum of idiopathic normal pressure hydrocephalus (iNPH) comprises the triad of gait disturbance, cognitive impairment, and urinary incontinence. However, motor abnormalities involving the upper extremities in iNPH patients have fe...
Guidelines 10 results
https://doi.org/10.1093/neuros/nyz265
Neurosurgery Blount JP, Durham SR et. al.
Aug 17th, 2019 - Myelomeningocele (MM) is the most common congenital anomaly to affect the nervous system and affects 1500-2000 newborn infants per year in the United States. It is accompanied by symptomatic hydrocephalus in approximately 70%-80% of patients. Diff...
https://doi.org/10.1093/neuros/nyz262
Neurosurgery Tamber MS, Flannery AM et. al.
Aug 17th, 2019 - Myelomeningocele (MM) is a condition that is responsible for considerable morbidity in the pediatric population. A significant proportion of the morbidity related to MM is attributable to hydrocephalus and the surgical management thereof. Postnata...
https://doi.org/10.1016/j.jacr.2019.02.024
Journal of the American College of Radiology : JACR; , Luttrull MD et. al.
May 6th, 2019 - Acute changes in mental status represent a broad collection of symptoms used to describe disorders in mentation and level of arousal, including the more narrowly defined diagnoses of delirium and psychosis. A wide range of precipitating factors ma...
https://doi.org/10.3171/2014.7.PEDS14322
Journal of Neurosurgery. Pediatrics; Mazzola CA, Choudhri AF et. al.
May 20th, 2015 - The objective of this systematic review and analysis was to answer the following question: What are the optimal treatment strategies for posthemorrhagic hydrocephalus (PHH) in premature infants? Both the US National Library of Medicine and the Coc...
https://doi.org/10.3171/2014.7.PEDS14323
Journal of Neurosurgery. Pediatrics; Flannery AM, Duhaime AC et. al.
May 20th, 2015 - This systematic review was undertaken to answer the following question: Do technical adjuvants such as ventricular endoscopic placement, computer-assisted electromagnetic guidance, or ultrasound guidance improve ventricular shunt function and surv...
Drugs 1 results see all →
Clinicaltrials.gov 72 results
https://clinicaltrials.gov/ct2/show/NCT05370131
May 11th, 2022 - Ventriculoperitoneal (VP) shunt is usually used in the treatment of hydrocephalus. However, VP shunt may have some complications. Children with shunts need good primary care. There have been significant advances in science and technology in recent...
https://clinicaltrials.gov/ct2/show/NCT04020198
May 5th, 2022 - This is an observational study looking at clinical and biomarker characteristics in patients with Parkinson's disease (PD), Multiple System Atrophy (MSA), Rapid Eye Movement Sleep Behavior Disorder (RBD), Normal Pressure Hydrocephalus (NPH) and ma...
https://clinicaltrials.gov/ct2/show/NCT03948256
May 2nd, 2022 - To assess the benefits and harms of two commonly used regimens for external ventricular drainage cessation in in patients with hydrocephalus following aneurysmal subarachnoid haemorrhage a randomized controlled setting. Design: Investigator-initia...
https://clinicaltrials.gov/ct2/show/NCT05326750
Apr 14th, 2022 - Double blinded, sham-controlled, randomized trial on repeated transcranial alternating current brain stimulation (tACS) in neurodegenerative diseases. The investigators will evaluate whether a 4-times daily repeated stimulation with gamma tACS on ...
https://clinicaltrials.gov/ct2/show/NCT03696043
Apr 6th, 2022 - External ventricular drain (EVD) placement is performed very often in neurosurgical practices. EVD's are used most commonly to monitor intracranial pressure and divert cerebrospinal fluid (CSF) in patients with increased intracranial pressures. Pa...
News 107 results
https://www.onclive.com/view/gd2-directed-car-t-cell-therapy-elicits-durable-benefit-in-h3k27m-mutated-diffuse-intrinsic-pontine-gliomas
May 2nd, 2022 - GD2-directed CAR T-cell therapy (GD2-CART) demonstrated prolonged periods of radiographic and clinical improvement in pediatric and young adult patients with H3K27M-mutated diffuse intrinsic pontine gliomas (DIPG) and spinal diffuse midline glioma...
https://www.medscape.com/viewarticle/959047
Sep 20th, 2021 - Folic acid is to be added to non-wholemeal wheat flour across the UK to help reduce neural tube defects in babies by around 20%, or 200 cases a year. The decision follows a consultation in 2019 and is based on evidence of successful fortification ...
https://www.medscape.com/viewarticle/944995
Feb 2nd, 2021 - Takeaway First trimester use of macrolide antibiotics (mainly erythromycin, spiramycin, clarithromycin and azithromycin) was not associated with an increased risk of congenital heart defects (CHDs) as a whole. Erythromycin, clarithromycin and azit...
https://www.medscape.com/viewarticle/943249
Jan 5th, 2021 - A patient asks an advanced practice registered nurse (APRN) to approve them for "medical marijuana." What are the clinician's responsibilities? The first hurdle is legal. In 18 states, an APRN has the legal authority to certify a patient to use ma...
https://www.onclive.com/view/atezolizumab-plus-vemurafenib-cobimetinib-impresses-in-braf-v600-melanoma
Dec 20th, 2020 - Grant A. McArthur, MBBS, PhD Treatment with atezolizumab (Tecentriq) in combination with vemurafenib (Zelboraf) and cobimetinib (Cotellic) was found to significantly improve progression-free survival (PFS) and produce durable responses versus vem...